Mymetics Corporation (MYMX) Return on Investment ROI from the third quarter of 2023 to third quarter of 2022 and for the year 2023, average high and low, overall ranking from Sep 30 2023 to Sep 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Mymetics Corporation  (MYMX)


Mymetics's ROI from its third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Mymetics's ROI in the third quarter of 2023?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Mymetics Corporation's return on investment (ROI) in its third quarter of 2023

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -84 -83 -75 -69 -71
Return On Investment (TTM) - - - - -
MYMX's Overall Ranking # # # # #
Seq. Investment Change TTM - - - - -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -14 -14 -7 -5 0

MYMX Company Profile >> Back to MYMX Roi Comparisons >> See Annual MYMX Return On Investment



Return On Investment MYMX's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Mymetics's III. Quarter Investments $ -84 Millions MYMX's Balance sheet
Mymetics's III. Quarter Income $ -1 Millions Quarterly MYMX's Income Statement
MYMX's Income by Division See MYMX's Income by Division


MYMX Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Investments in Millions -69 0 0 -51 9
Y / Y Investment Growth - 1.26 % - - -25.27 %
Net Income in Millions -5 -5 -4 -5 -5
Y / Y Net Income Growth - - - - -
Annual Return On Investment - -4641.17 % -4131.23 % - -55.65 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
MYMX's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for MYMX's Competitors
Subscribers only: Roi for Mymetics's Suppliers
Subscribers only: Return On Investment for MYMX's Customers

Other Ratios
MYMX's Roa MYMX's Inventory Turnover Ratio MYMX's Growth Rates MYMX's Dividend Statistics
MYMX's Profitability Ratios MYMX's Asset Turnover Ratio MYMX's Dividend Growth
MYMX's Roe MYMX's Valuation Ratios MYMX's Financial Strength Ratios MYMX's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2023, within Healthcare Sector ROI
Elite Pharmaceuticals Inc   47.02 %
Gyre Therapeutics Inc   45.47 %
Star Equity Holdings Inc   44.42 %
Idexx Laboratories Inc  43.85 %
Entera Bio Ltd   41.70 %
Zymeworks Inc   39.50 %
Medpace Holdings Inc   38.76 %
Lite Strategy Inc   38.41 %
Enzo Biochem Inc  38.07 %
Northview Acquisition Corp  37.67 %
Mettler toledo International Inc   33.97 %
Semler Scientific inc   30.96 %
Escalon Medical Corp   30.94 %
Nrc Health  30.72 %
Vaso Corporation  29.37 %
Denali Therapeutics Inc   29.23 %
Shockwave Medical Inc   28.94 %
Arcturus Therapeutics Holdings Inc   28.09 %
Johnson and Johnson  25.57 %
Protalix Biotherapeutics inc   25.29 %
Tao Synergies Inc   24.90 %
Harmony Biosciences Holdings inc   23.56 %
Voyager Therapeutics Inc   23.09 %
Iradimed Corporation  21.83 %
Vertex Pharmaceuticals Inc  20.88 %
Pro dex Inc   20.79 %
Point Biopharma Global Inc   20.60 %
Tenax Therapeutics Inc   19.63 %
Bellicum Pharmaceuticals Inc   19.61 %
Chemed Corporation  18.89 %

Date modified: 2026-09-30T13:42:16+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.